ACC Inhibition by Lanatoside C: A Repurposed MASH Therapy

Lanatoside C demonstrates promise as a repurposed ACC inhibitor for MASH treatment, offering a cost-effective repurposing strategy to advance therapeutic options for MASH.

Authors

Institutions

Publication Details

Journal
Combinatorial Chemistry & High Throughput Screening
Published
2026-01-08
DOI
https://doi.org/10.2174/0113862073405993251117054929
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ACC Inhibition by Lanatoside C: A Repurposed MASH Therapy

Bin Xiao, Xianxiang Bai, Rubin Duan
Combinatorial Chemistry & High Throughput Screening
Liver Disease Diagnosis and Treatment
article

ACC Inhibition by Lanatoside C: A Repurposed MASH Therapy

Bin Xiao, Xianxiang Bai, Rubin Duan
article en

Abstract

Lanatoside C demonstrates promise as a repurposed ACC inhibitor for MASH treatment, offering a cost-effective repurposing strategy to advance therapeutic options for MASH.

Combinatorial Chemistry & High Throughput ScreeningVol. 29
Inner Mongolia Medical University (CN)
Openalex Percentile: Top 86%
Liver Disease Diagnosis and Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ACC Inhibition by Lanatoside C: A Repurposed MASH Therapy — Bin Xiao, Xianxiang Bai, et al. · Combinatorial Chemistry & High Throughput Screening (2026) | TGRS Research Map | TGRS